HomeNDC LookupRxCUI directory › RxCUI 889616

Chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule [Librax] — RxCUI 889616

RxNorm drug concept · Semantic branded drug
RxCUI 889616 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI889616
Official nameChlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule [Librax]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLibrax 5 MG / 2.5 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chlordiazepoxide and Clidinium: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It combines two drugs in one capsule to tackle digestive problems from two directions. One ingredient — chlordiazepoxide — calms the anxiety and tension that often make gut symptom...
  • What exactly is this medication supposed to do for me?
  • No — please avoid alcohol entirely while you're on this medication. Both alcohol and this drug slow down your central nervous system, and combining them greatly increases the risk...
  • Yes, drowsiness is one of the most common side effects — especially when you first start or if your dose is adjusted. It tends to be more noticeable in older adults. Avoid driving...
📖 Read our full Chlordiazepoxide and Clidinium guide →

🕸️ Concept Web — How Chlordiazepoxide hydrochloride 5 MG / clidinium... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule [Librax] RxCUI 889616

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Chlordiazepoxide 2356
    • Clidinium 21232
    • Chlordiazepoxide / clidinium 611854
    • Chlordiazepoxide hydrochloride 203173
    • Clidinium bromide 48212
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Librax 28697
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlordiazepoxide / clidinium Oral Capsule 374581
    • Chlordiazepoxide hydrochloride / clidinium bromide Oral Capsule 2647389
    • Chlordiazepoxide / clidinium Oral Product 1153318
    • Chlordiazepoxide / clidinium Pill 1153319
    • Chlordiazepoxide hydrochloride / clidinium bromide Oral Product 2663376
    • Chlordiazepoxide hydrochloride / clidinium bromide Pill 2661380
    • Chlordiazepoxide / clidinium Oral Capsule [Librax] 366468
    • Chlordiazepoxide hydrochloride / clidinium bromide Oral Capsule [Librax] 2656936
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule SCD · 889614
  • Chlordiazepoxide hydrochloride 5 MG SCDC · 889613
  • Clidinium bromide 2.5 MG SCDC · 315696
  • Chlordiazepoxide / clidinium Oral Capsule SCDF · 374581
  • Chlordiazepoxide hydrochloride / clidinium bromide Oral Capsule SCDFP · 2647389
  • Chlordiazepoxide / clidinium Oral Product SCDG · 1153318
  • Chlordiazepoxide / clidinium Pill SCDG · 1153319
  • Chlordiazepoxide hydrochloride / clidinium bromide Oral Product SCDGP · 2663376
  • Chlordiazepoxide hydrochloride / clidinium bromide Pill SCDGP · 2661380

Brand-Name Concepts

  • Chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG [Librax] SBDC · 889615
  • Chlordiazepoxide / clidinium Oral Capsule [Librax] SBDF · 366468
  • Chlordiazepoxide hydrochloride / clidinium bromide Oral Capsule [Librax] SBDFP · 2656936
  • Librax Oral Product SBDG · 1186173
  • Librax Pill SBDG · 1186174
  • Librax BN · 28697

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 889616 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-4100-10 100 CAPSULE in 1 BOTTLE (0187-4100-10) Librax Bausch Health US, LLC 1966-09-01
Observed labelers: Bausch Health US, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.